Zobrazeno 1 - 10
of 479
pro vyhledávání: '"Hans-Peter Volz"'
Autor:
Markus Dold, Hans-Jürgen Möller, Hans-Peter Volz, Erich Seifritz, Sandra Schläfke, Lucie Bartova, Siegfried Kasper
Publikováno v:
European Psychiatry, Vol 67 (2024)
The influence of baseline severity on the efficacy of Silexan, a proprietary essential oil from Lavandula angustifolia, in anxiety disorders has not been investigated in a pooled dataset. We report on an individual patient data analysis of all five d
Externí odkaz:
https://doaj.org/article/59fec36673804aceac6eb4542d3e1459
Publikováno v:
International Journal of Psychiatry in Clinical Practice. :1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6decdb0a677176388a8007d67a64b98
https://doi.org/10.1080/13651501.2023.2187308
https://doi.org/10.1080/13651501.2023.2187308
Publikováno v:
International Journal of Psychiatry in Clinical Practice. 27:92-106
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b5c727b6029852c4dc898b2dae120ed
https://doi.org/10.1080/13651501.2022.2087530
https://doi.org/10.1080/13651501.2022.2087530
Autor:
Hans-Peter Volz
Publikováno v:
Zeitschrift für Phytotherapie. 43:99-104
ZusammenfassungJohanniskrautextrakte enthalten eine Vielzahl von Stoffen, die einzelnen Extrakte können sich beträchtlich unterscheiden, was bei ihrer Auswahl und Beurteilung berücksichtigt werden muss. Mittlerweile liegen robuste Daten zum Wirkme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c767fd3cbc92aabb6a29dd6775d6e84
https://doi.org/10.1055/a-1773-4197
https://doi.org/10.1055/a-1773-4197
Autor:
Hans-Peter Volz
Publikováno v:
Zeitschrift für Phytotherapie. 43:105-111
ZusammenfassungAngststörungen sind als Gruppe betrachtet die häufigsten psychiatrischen Erkrankungen überhaupt, die Ein-Jahres-Prävalenz beträgt 14%. In dem vorliegenden Beitrag werden zunächst die wichtigsten klinischen Charakteristika dieser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6958c69871f0501563e7879c6634d885
https://doi.org/10.1055/a-1883-6090
https://doi.org/10.1055/a-1883-6090
Autor:
Lucie Bartova, Markus Dold, Hans-Peter Volz, Erich Seifritz, Hans-Jürgen Möller, Siegfried Kasper
Publikováno v:
European Archives of Psychiatry and Clinical Neuroscience. 273:51-63
Silexan is a proprietary active substance produced from Lavandula angustifolia, with proven anxiolytic efficacy in subthreshold and generalized anxiety disorder as well as in mixed anxiety and depressive disorder with beneficial impact on anxiety-rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ae82cb620ecd13b5b695e80e852f978
https://doi.org/10.1007/s00406-022-01390-z
https://doi.org/10.1007/s00406-022-01390-z
Autor:
Markus Dold, Lucie Bartova, Hans-Peter Volz, Erich Seifritz, Hans-Jürgen Möller, Sandra Schläfke, Siegfried Kasper
Publikováno v:
European Archives of Psychiatry and Clinical Neuroscience.
Introduction We report on a meta-analysis of Silexan, a proprietary active substance produced from Lavandula angustifolia, in subthreshold anxiety, mixed anxiety and depressive disorder (MADD), and generalized anxiety disorder (GAD). Methods The pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::943c93e1e221956d967b239c03d241b2
https://doi.org/10.1007/s00406-022-01547-w
https://doi.org/10.1007/s00406-022-01547-w
The diagnosis of anxiety disorders, like other psychiatric disorders also, is operationalised since the introduction of diagnostic manuals. The diagnostic criteria of Generalised Anxiety Disorder (GAD) have been tightened in the last decades. This le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a7dafae86cf7596ba44c4054fefde73
https://doi.org/10.5167/uzh-222760
https://doi.org/10.5167/uzh-222760
Autor:
Talar Hopyan, Anna Wacker, Sandra Schläfke, Walter E. Müller, Hans-Peter Volz, Hans-Jürgen Möller, Erich Seifritz, Siegfried Kasper
Publikováno v:
International Journal of Neuropsychopharmacology
Background Silexan is a lavender essential oil with established anxiolytic and calming efficacy. Here we asked whether there is a potential for abuse in human patients. Methods We carried out a phase I abuse liability single-center, double-blind, 5-w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50a4177cc9f8c1198fe1e3a112cb73b0
http://europepmc.org/articles/PMC7968617
http://europepmc.org/articles/PMC7968617